285 related articles for article (PubMed ID: 20424477)
1. Possible relationship between neutrophil gelatinase-associated lipocalin, hepcidin, and inflammation in haemodialysed patients.
Malyszko J; Malyszko JS; Kozminski P; Koc-Zorawska E; Mysliwiec M; Macdougall I
Nephron Clin Pract; 2010; 115(4):c268-75. PubMed ID: 20424477
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil gelatinase-associated lipocalin (NGAL) in chronic cardiorenal failure is correlated with endogenous erythropoietin levels and decreases in response to low-dose erythropoietin treatment.
Emans ME; Braam B; Diepenbroek A; van der Putten K; Cramer MJ; Wielders JP; Swinkels DW; Doevendans PA; Gaillard CA
Kidney Blood Press Res; 2012; 36(1):344-54. PubMed ID: 23235391
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil gelatinase-associated lipocalin in dialyzed patients is related to residual renal function, type of renal replacement therapy and inflammation.
Malyszko J; Malyszko JS; Koc-Zorawska E; Kozminski P; Mysliwiec M
Kidney Blood Press Res; 2009; 32(6):464-9. PubMed ID: 20068352
[TBL] [Abstract][Full Text] [Related]
4. Type of renal replacement therapy and residual renal function may affect prohepcidin and hepcidin.
Malyszko J; Malyszko JS; Kozminski P; Mysliwiec M
Ren Fail; 2009; 31(10):876-83. PubMed ID: 20030521
[TBL] [Abstract][Full Text] [Related]
5. Can serum NGAL levels be used as an inflammation marker on hemodialysis patients with permanent catheter?
Yigit IP; Celiker H; Dogukan A; Ilhan N; Gurel A; Ulu R; Aygen B
Ren Fail; 2015 Feb; 37(1):77-82. PubMed ID: 25347233
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients.
Bolignano D; Coppolino G; Romeo A; De Paola L; Buemi A; Lacquaniti A; Nicocia G; Lombardi L; Buemi M
Nephrol Dial Transplant; 2009 Nov; 24(11):3398-403. PubMed ID: 19549696
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil gelatinase-associated lipocalin and hepcidin: what do they have in common and is there a potential interaction?
Malyszko J; Tesar V; Macdougall IC
Kidney Blood Press Res; 2010; 33(2):157-65. PubMed ID: 20502037
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein but not hepcidin, NGAL and transferrin determines the ESA resistance in hemodialysis patients.
Yılmaz I; Ozkok A; Kostek O; Kolukısa A; Duran I; Odabaş AR; Kemal Işman F; Işbilen Başok B
Ren Fail; 2016; 38(1):89-95. PubMed ID: 26539647
[TBL] [Abstract][Full Text] [Related]
9. Low Serum Neutrophil Gelatinase-associated Lipocalin Level as a Marker of Malnutrition in Maintenance Hemodialysis Patients.
Imamaki H; Ishii A; Yokoi H; Kasahara M; Kuwabara T; Mori KP; Kato Y; Kuwahara T; Satoh M; Nakatani K; Saito Y; Tomosugi N; Sugawara A; Nakao K; Mukoyama M; Yanagita M; Mori K
PLoS One; 2015; 10(7):e0132539. PubMed ID: 26161663
[TBL] [Abstract][Full Text] [Related]
10. Plasma neutrophil gelatinase-associated lipocalin is associated with iron status in anemic patients with pre-dialysis chronic kidney disease.
Kim IY; Kim JH; Lee DW; Lee SB; Rhee H; Song SH; Seong EY; Kwak IS
Clin Exp Nephrol; 2018 Feb; 22(1):28-34. PubMed ID: 28389813
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of serum NGAL and hepcidin levels in chronic kidney disease patients.
Avci Çiçek E; Rota S; Dursun B; Kavalci E
Ren Fail; 2016; 38(1):35-9. PubMed ID: 26627016
[TBL] [Abstract][Full Text] [Related]
12. A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients.
Malyszko J; Malyszko JS; Mysliwiec M
Transplant Proc; 2009 Oct; 41(8):3056-9. PubMed ID: 19857675
[TBL] [Abstract][Full Text] [Related]
13. The relationship of Prohepcidin levels with anemia and inflammatory markers in non-diabetic uremic patients: a controlled study.
Aydin Z; Gursu M; Karadag S; Uzun S; Sumnu A; Doventas Y; Ozturk S; Kazancioglu R
Ren Fail; 2014 Sep; 36(8):1253-7. PubMed ID: 25040737
[TBL] [Abstract][Full Text] [Related]
14. Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Am J Hematol; 2006 Nov; 81(11):832-7. PubMed ID: 16929540
[TBL] [Abstract][Full Text] [Related]
15. Plasma neutrophil gelatinase-associated lipocalin levels are markedly increased in patients with non-transfusion-dependent thalassemia: Lack of association with markers of erythropoiesis, iron metabolism and renal function.
Patsaoura A; Tatsi E; Margeli A; Kanavaki I; Delaporta P; Kyriakopoulou D; Kouraklis-Symeonidis A; Kattamis A; Papassotiriou I
Clin Biochem; 2014 Aug; 47(12):1060-4. PubMed ID: 24721683
[TBL] [Abstract][Full Text] [Related]
16. Hepcidin, an acute-phase protein and a marker of inflammation in kidney transplant recipients with and without coronary artery disease.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2006 Nov; 38(9):2895-8. PubMed ID: 17112858
[TBL] [Abstract][Full Text] [Related]
17. Hemojuvelin and iron metabolism in kidney and heart allograft recipients.
Przybylowski P; Koc-Zorawska E; Glowinska I; Levin-Iaina N; Macdougall IC; Malyszko JS; Mysliwiec M; Malyszko J
Transplant Proc; 2013; 45(1):391-3. PubMed ID: 23375327
[TBL] [Abstract][Full Text] [Related]
18. Iron metabolism, hepcidin, and anemia in orthotopic heart transplantation recipients treated with mammalian target of rapamycin.
Przybylowski P; Malyszko JS; Macdougall IC; Malyszko J
Transplant Proc; 2013; 45(1):387-90. PubMed ID: 23375326
[TBL] [Abstract][Full Text] [Related]
19. Is hemojuvelin a possible new player in iron metabolism in hemodialysis patients?
Malyszko J; Malyszko JS; Levin-Iaina N; Koc-Zorawska E; Kozminski P; Mysliwiec M
Int Urol Nephrol; 2012 Dec; 44(6):1805-11. PubMed ID: 22130959
[TBL] [Abstract][Full Text] [Related]
20. Is hepcidin a link between anemia, inflammation and liver function in hemodialyzed patients?
Małyszko J; Małyszko JS; Hryszko T; Pawlak K; Mysliwiec M
Am J Nephrol; 2005; 25(6):586-90. PubMed ID: 16254410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
